Pub Date : 2022-03-01DOI: 10.4067/s0717-92272022000100075
Álvaro Araya, N. González, J. Vallejos, Sergio Ruiz
{"title":"El impacto de la resiliencia en la esquizofrenia: una revisión sistemática cualitativa.","authors":"Álvaro Araya, N. González, J. Vallejos, Sergio Ruiz","doi":"10.4067/s0717-92272022000100075","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100075","url":null,"abstract":"","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42073870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-01DOI: 10.4067/s0717-92272022000100040
María José Bracho P, Aitana Grasso-Cladera, Christian Salas R
Background: Anorexia nervosa (AN) and bulimia nervosa (BN) are severe and chronic mental health illnesses that affect a high percentage of the population. A growing number of studies have reported neuropsychological impairments in this population, apparently contributing to the onset and progression of the disorder, and impacting on treatment efficacy and recovery. Methodology: This Narrative Review aimed to summarize findings regarding the neuropsychological profile of women with AN and BN at different treatment phases. Results: Available evidence suggests that women with AN and BN present a profile of executive and social cognition deficits. These results are consistent with evidence from neuroimaging findings of structural brain alterations in frontal areas and frontal-subcortical circuits. Conclusions: Knowledge about the neuropsychological profiles of AN and BN women offers key information to understand the clinical presentation of this population and challenges in adhering and benefiting from treatment. Future studies should explore the efficacy of interventions targeting neuropsychological impairments and how they contribute to treatment as usual.
{"title":"Déficits neuropsicológicos en mujeres con trastornos de la conducta alimentaria","authors":"María José Bracho P, Aitana Grasso-Cladera, Christian Salas R","doi":"10.4067/s0717-92272022000100040","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100040","url":null,"abstract":"Background: Anorexia nervosa (AN) and bulimia nervosa (BN) are severe and chronic mental health illnesses that affect a high percentage of the population. A growing number of studies have reported neuropsychological impairments in this population, apparently contributing to the onset and progression of the disorder, and impacting on treatment efficacy and recovery. Methodology: This Narrative Review aimed to summarize findings regarding the neuropsychological profile of women with AN and BN at different treatment phases. Results: Available evidence suggests that women with AN and BN present a profile of executive and social cognition deficits. These results are consistent with evidence from neuroimaging findings of structural brain alterations in frontal areas and frontal-subcortical circuits. Conclusions: Knowledge about the neuropsychological profiles of AN and BN women offers key information to understand the clinical presentation of this population and challenges in adhering and benefiting from treatment. Future studies should explore the efficacy of interventions targeting neuropsychological impairments and how they contribute to treatment as usual.","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46388393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-01DOI: 10.4067/s0717-92272022000100051
María Ignacia Retamal, Elisa Sepúlveda, J. Cortés, F. Barraza, M. Arancibia
{"title":"Desensibilización y reprocesamiento por movimientos oculares (EMDR) para trastornos ansiosos y depresivos en niños y adolescentes: revisión de la evidencia disponible.","authors":"María Ignacia Retamal, Elisa Sepúlveda, J. Cortés, F. Barraza, M. Arancibia","doi":"10.4067/s0717-92272022000100051","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100051","url":null,"abstract":"","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45104327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-01DOI: 10.4067/s0717-92272022000100124
F. Vergara, T. Ramos, Nicolás Rebolledo, S. Soto
{"title":"Síndrome de la mano inútil con astereognosia secundaria a un astrocitoma cervical.","authors":"F. Vergara, T. Ramos, Nicolás Rebolledo, S. Soto","doi":"10.4067/s0717-92272022000100124","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100124","url":null,"abstract":"","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44729055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-01DOI: 10.4067/s0717-92272022000100116
Jesús Amador L., Sandra González A., Lorys Osses, Alvino De León, G. González
Introduction: an arachnoid cyst is caused by the alteration of one of the membranes of the meninges (arachnoid), predominantly in the middle cranial fossa; It is an uncommon pathology that causes symptoms and if they occur, neuropsychiatric manifestations may take place. Objective: expose the clinical data; and the diagnostic and therapeutic methodology. Case: we present a 24-year-old female patient; with no personal history of psychiatric and known non-psychiatric medical records, whom presents a story with a month of evolution of psychotic symptoms and behavioral changes. A simple cerebral CAT was performed and then a cerebral magnetic resonance imaging with contrast to define the size of the arachnoid cyst, due to the possible neuropsychiatric symptoms found. Through laboratory tests, electrophysiological studies (electroencephalogram), neuroimaging and clinical evaluation. It was decided to present the clinical characteristics of the patient who required management with antipsychotics, benzodiazepines and mood stabilizer with gradual improvement of her admission symptoms (psychomotor agitation and psychosis)
{"title":"Quiste aracnoideo (Galassi Tipo II) y síntomas neuropsiquiátricos: a propósito de un caso.","authors":"Jesús Amador L., Sandra González A., Lorys Osses, Alvino De León, G. González","doi":"10.4067/s0717-92272022000100116","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100116","url":null,"abstract":"Introduction: an arachnoid cyst is caused by the alteration of one of the membranes of the meninges (arachnoid), predominantly in the middle cranial fossa; It is an uncommon pathology that causes symptoms and if they occur, neuropsychiatric manifestations may take place. Objective: expose the clinical data; and the diagnostic and therapeutic methodology. Case: we present a 24-year-old female patient; with no personal history of psychiatric and known non-psychiatric medical records, whom presents a story with a month of evolution of psychotic symptoms and behavioral changes. A simple cerebral CAT was performed and then a cerebral magnetic resonance imaging with contrast to define the size of the arachnoid cyst, due to the possible neuropsychiatric symptoms found. Through laboratory tests, electrophysiological studies (electroencephalogram), neuroimaging and clinical evaluation. It was decided to present the clinical characteristics of the patient who required management with antipsychotics, benzodiazepines and mood stabilizer with gradual improvement of her admission symptoms (psychomotor agitation and psychosis)","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47500785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-01DOI: 10.4067/s0717-92272022000100102
Mariana Sinning O, Ariel Fariña B, Raúl Valenzuela M, Carlos Bennett C, Rodrigo Riveros P, Francisco Torres, P. Paredes M, Roger Gejman E, Ronny Muñoz M, Juvenal A. Ríos
Brain tumors are characterized by high morbidity and mortality. The vast majority correspond to secondary tumors (metastasis). On the other hand, within the primary tumors of the central nervous system, gliomas correspond to 30% of these. In the US, between 2007-2011, an approximate incidence of 21.4 cases per 100,000 inhabitants was estimated. Recent advances in the molecular understanding of the biology of these tumors have made it possible to substantially improve their classification, allowing a better correlation with clinical outcomes and prognosis. Along these lines, today, it is possible to stratify patients by risk and deliver treatments capable of prolonging global survival between 5-7 years, for grade II and III gliomas. The present consensus, prepared by a multidisciplinary panel of experts from various Chilean scientific societies and, therefore, from all the specialties involved in the medical and surgical therapy. Enlightened from the molecular oncology, this proposal offers an input of clinical utility, which, together with an updated review in relation to the treatment and follow-up of these patients, allows us to understand the relevance of these biomarkers in precision disease management. It should be noted that this manuscript emerges from the same work force, which prepared the Clinical Protocol for Adult Gliomas 2019, published by the Ministry of Health, and that differs from it, which offers clinical-operative details, such as flowcharts and dose, our review attempts to reveal imaging and molecular advances and how they impact the current management of the disease.
{"title":"Consenso Chileno Para el Diagnóstico y Tratamiento De Gliomas del Adulto","authors":"Mariana Sinning O, Ariel Fariña B, Raúl Valenzuela M, Carlos Bennett C, Rodrigo Riveros P, Francisco Torres, P. Paredes M, Roger Gejman E, Ronny Muñoz M, Juvenal A. Ríos","doi":"10.4067/s0717-92272022000100102","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100102","url":null,"abstract":"Brain tumors are characterized by high morbidity and mortality. The vast majority correspond to secondary tumors (metastasis). On the other hand, within the primary tumors of the central nervous system, gliomas correspond to 30% of these. In the US, between 2007-2011, an approximate incidence of 21.4 cases per 100,000 inhabitants was estimated. Recent advances in the molecular understanding of the biology of these tumors have made it possible to substantially improve their classification, allowing a better correlation with clinical outcomes and prognosis. Along these lines, today, it is possible to stratify patients by risk and deliver treatments capable of prolonging global survival between 5-7 years, for grade II and III gliomas. The present consensus, prepared by a multidisciplinary panel of experts from various Chilean scientific societies and, therefore, from all the specialties involved in the medical and surgical therapy. Enlightened from the molecular oncology, this proposal offers an input of clinical utility, which, together with an updated review in relation to the treatment and follow-up of these patients, allows us to understand the relevance of these biomarkers in precision disease management. It should be noted that this manuscript emerges from the same work force, which prepared the Clinical Protocol for Adult Gliomas 2019, published by the Ministry of Health, and that differs from it, which offers clinical-operative details, such as flowcharts and dose, our review attempts to reveal imaging and molecular advances and how they impact the current management of the disease.","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45236638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-01DOI: 10.4067/s0717-92272022000100092
Armando Nader N.
The present article gives emphasis in reconsidering the work of Pierre Janet in trauma and dissociative amnesia, as important aspects for the contemporary study of posttraumatic stress disorder (PTSD). The purpose of this non systematic historical review is to explain the following ideas under Janet ́s perspective: a) the concept of fixed idea, denominated in our contemporary nomenclature as trauma, b) to describe the different types of amnesia described by Janet and its relation with DSM clasiffication for this penomenon, and c) to show through the analysis of a clinical case described by Janet, how a concordance exists between the current denomination of complex PTSD and what Janet nominated “one of the forms in which hysteria can presents after an emotional accident”. This article is mainly based in some original chapters from Janet ́s work published in French.
{"title":"Trauma y Amnesia Disociativa: La visión de Pierre Janet.","authors":"Armando Nader N.","doi":"10.4067/s0717-92272022000100092","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100092","url":null,"abstract":"The present article gives emphasis in reconsidering the work of Pierre Janet in trauma and dissociative amnesia, as important aspects for the contemporary study of posttraumatic stress disorder (PTSD). The purpose of this non systematic historical review is to explain the following ideas under Janet ́s perspective: a) the concept of fixed idea, denominated in our contemporary nomenclature as trauma, b) to describe the different types of amnesia described by Janet and its relation with DSM clasiffication for this penomenon, and c) to show through the analysis of a clinical case described by Janet, how a concordance exists between the current denomination of complex PTSD and what Janet nominated “one of the forms in which hysteria can presents after an emotional accident”. This article is mainly based in some original chapters from Janet ́s work published in French.","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47676499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-01DOI: 10.4067/s0717-92272022000100026
Nelson Barrientos U., Raúl Juliet P., Alan Rapoport, Philipe Salles G, Anna Milán S., Paulina Meza C.
Introduction: Clinical markers of medication overuse headache (MOH) are based on headache classification developed by the International Headache Society (IHS). This classification include only two criteria: frequency of headache days must be 15 or more days per month for at least three or more months; and the number of days of overuse medication must be either 10 or 15 days per month depending on the type of medication. However, patients often have others distinct associated clinical markers, which are overlooked by most physicians during the initial evaluation. Methodology: This study is a prospective, longitudinal and observational study of 76 patients admitted to DIPRECA ́s hospital Headache Unit. They were all diagnosed with, MOH according to the criteria established by the his ICHD III beta.(1) Patients were given standard treatment including detoxification and preventive medications and followed for 6 months. Symptoms of interest were recorded in at each clinical monitoring visit and assessment scales such as Zung, MIDAS, HIT-6 were administered. Results: Overused medications included nonsteroidal anti-inflammatory drugs (NSAIDs), triptans and ergots. The most significant clinical symptoms associated were: awaking in the morning with headache, awaking the patient at dawn by headache, attention difficulties, depression, cervical pain and myofascial pain syndrome. All symptoms significantly improved when treatment began, as did quality of life as measured by MIDAS and HIT-6 scales. Discussion: In evaluating patients with MOH consider both the ICHD III beta diagnostic criteria and the common and specific symptoms seen in most cases of MOH.
药物过度使用性头痛(MOH)的临床标志是基于国际头痛学会(IHS)制定的头痛分类。该分类仅包括两个标准:头痛天数的频率必须为每月15天或以上，至少持续3个月或以上;过度使用药物的天数必须是每月10天或15天，这取决于药物的类型。然而，患者通常还有其他明显的相关临床标志，这些标志在最初的评估中被大多数医生所忽视。方法:本研究是一项前瞻性、纵向和观察性研究，纳入了DIPRECA医院头痛科收治的76例患者。(1)给予包括排毒和预防性药物在内的标准治疗，随访6个月。在每次临床监测访问时记录感兴趣的症状，并使用Zung, MIDAS, HIT-6等评估量表。结果:过度使用的药物包括非甾体抗炎药(NSAIDs)、曲坦类药物和麦角糖。最显著的临床症状为:早晨醒来头痛、黎明醒来头痛、注意力困难、抑郁、颈痛和肌筋膜疼痛综合征。治疗开始后，所有症状均显著改善，MIDAS和HIT-6量表测量的生活质量也有所改善。讨论:在评估MOH患者时，既要考虑ICHD III β诊断标准，也要考虑在大多数MOH病例中出现的常见和特定症状。
{"title":"Cefalea por abuso de medicamentos y sus marcadores clínicos","authors":"Nelson Barrientos U., Raúl Juliet P., Alan Rapoport, Philipe Salles G, Anna Milán S., Paulina Meza C.","doi":"10.4067/s0717-92272022000100026","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100026","url":null,"abstract":"Introduction: Clinical markers of medication overuse headache (MOH) are based on headache classification developed by the International Headache Society (IHS). This classification include only two criteria: frequency of headache days must be 15 or more days per month for at least three or more months; and the number of days of overuse medication must be either 10 or 15 days per month depending on the type of medication. However, patients often have others distinct associated clinical markers, which are overlooked by most physicians during the initial evaluation. Methodology: This study is a prospective, longitudinal and observational study of 76 patients admitted to DIPRECA ́s hospital Headache Unit. They were all diagnosed with, MOH according to the criteria established by the his ICHD III beta.(1) Patients were given standard treatment including detoxification and preventive medications and followed for 6 months. Symptoms of interest were recorded in at each clinical monitoring visit and assessment scales such as Zung, MIDAS, HIT-6 were administered. Results: Overused medications included nonsteroidal anti-inflammatory drugs (NSAIDs), triptans and ergots. The most significant clinical symptoms associated were: awaking in the morning with headache, awaking the patient at dawn by headache, attention difficulties, depression, cervical pain and myofascial pain syndrome. All symptoms significantly improved when treatment began, as did quality of life as measured by MIDAS and HIT-6 scales. Discussion: In evaluating patients with MOH consider both the ICHD III beta diagnostic criteria and the common and specific symptoms seen in most cases of MOH.","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44800663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-01DOI: 10.4067/s0717-92272022000100013
A. L. Núñez-Muñoz, A. Soto, J. D. Roca-Sánchez-Moreno, D. M. Quiñones-Laveriano, S. Indacochea-Cáceda, J. D. L. Cruz-Vargas
{"title":"Asociación Entre Enfermedades Cardiometabólicas y Depresión En Un Hospital De Referencia Peruano","authors":"A. L. Núñez-Muñoz, A. Soto, J. D. Roca-Sánchez-Moreno, D. M. Quiñones-Laveriano, S. Indacochea-Cáceda, J. D. L. Cruz-Vargas","doi":"10.4067/s0717-92272022000100013","DOIUrl":"https://doi.org/10.4067/s0717-92272022000100013","url":null,"abstract":"","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44913278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-12-01DOI: 10.4067/s0717-92272021000400269
Ferran Padrós B., María Elena Guzmán B.
{"title":"Desarrollo y estudio psicométrico de la Escala de Susceptibilidad al Castigo Anticipado (ESCA)","authors":"Ferran Padrós B., María Elena Guzmán B.","doi":"10.4067/s0717-92272021000400269","DOIUrl":"https://doi.org/10.4067/s0717-92272021000400269","url":null,"abstract":"","PeriodicalId":39300,"journal":{"name":"Revista Chilena de Neuro-Psiquiatria","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49527407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：